New survey aims to better measure life quality in pituitary tumor patients
NCT ID NCT04106531
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new questionnaire called Prolac-10 to see if it can accurately measure quality of life in people with prolactinoma (a type of pituitary tumor) who are starting medical treatment. Only 8 people took part before the study was stopped early. The goal was to check if the survey is reliable and consistent, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PITUITARY TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ohio State University
Columbus, Ohio, 43210, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple eye-tracking test may replace button-pressing exams for pituitary tumor patients
- Immunotherapy combo shows promise for tough pituitary tumors
- Scientists hunt for hidden genes behind pituitary tumors
- Scientists map immune cells in pituitary tumors to unlock new treatments
- How do patients feel after Nose-Based brain surgery? new study aims to find out
- Nerve block could make brain tumor surgery safer and less painful